Competitive Assessment of Pre-launch Marketing Expenses in the Pharmaceutical Industry in the EMEA Region

August 29, 2016

Business Challenge

An Asian pharmaceutical company was interested in assessing the direct and indirect pre-launch marketing expenses, for prescriptions drugs, of its competitors in the US to streamline its own expenditure.


The client was unable to implement its ambitious new prescription drug launch plan within its budget and wanted to assess its competitors’ pre-launch marketing expenditure to optimize its own expenses and cut down the spending on unnecessary marketing programs.


We conducted an in-depth competitive assessment including 25+ interviews to determine the pre-launch marketing expenditure strategies of the company’s competitors and benchmarked the company’s spend data against that of its competitors to provide inputs on cost-cutting strategies.


The client was able to plan its spend strategy, eliminate its non-necessary expenses, and prioritize its marketing expenditure, thus obtaining cost savings of up to 15% on its budget.

We help our clients make smarter decisions to achieve rapid business growth

Our strength lies in the unrivaled diversity of our international market research teams, innovative research methodologies, and unique viewpoints that merge seamlessly to offer customized solutions for your every business requirement.

Sorry, we no longer support Internet Explorer. Please upgrade to latest version of Microsoft Edge, Google Chrome, or Firefox.